Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: Colonic dysbiosis contributes to the development of colonic inflammation in ulcerative colitis (UC). Fecal microbial transplantation (FMT) is being proposed as a novel treatment for UC because it can eliminate dysbiosis; however, no prospective data exist. We initiated a pilot study to evaluate feasibility and safety of FMT in children with UC. METHODS: Ten children, 7 to 21 years of age, with mild-to-moderate UC (pediatric UC activity index [PUCAI] between 15 and 65) received freshly prepared fecal enemas daily for 5 days. Data on tolerability, adverse events, and disease activity were collected during FMT and weekly for 4 weeks after FMT. Clinical response was defined as decrease in PUCAI by >15, and decrease in PUCAI to <10 was considered clinical remission. RESULTS: No serious adverse events were noted. Mild (cramping, fullness, flatulence, bloating, diarrhea, and blood in stool) to moderate (fever) adverse events were self-limiting. One subject could not retain fecal enemas. Average tolerated enema volume by remaining 9 subjects was 165 mL/day. After FMT, 7 of the 9 (78%) subjects showed clinical response within 1 week, 6 of the 9 (67%) subjects maintained clinical response at 1 month, and 3 of the 9 (33%) subjects achieved clinical remission at 1 week after FMT. Median PUCAI significantly improved after FMT (P = 0.03) compared with the baseline. CONCLUSIONS: Fecal enemas were feasible and tolerated by children with UC. Adverse events were acceptable, self-limiting, and manageable by subjects. FMT indicated efficacy in the treatment of UC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These reports were followed by a number of small studies of FMT in children and adults with UC, CD, and pouchitis with mixed results.64–72”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [68]
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 6×
“A recent study (7) evaluating the role of FMT in treating recurrent C difficile infection reported adverse events, which, similar to our study, were predominantly GI symptoms.”
BackgroundMethodResultInfluentialDysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713 · cited 1×
“The colonic microbiome in patients with UC has decreased richness and diversity (2,3) and is dysfunctional (4) (dysbiosis).”
BackgroundTurner, D., Otley, A. R., Mack, D., Hyams, J., de Bruijne, J., Uusoue, K., Walters, T. D., Zachos, M., Mamula, P., Beaton, D. E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.029 · Cited by 1,072 · cited 2×
“Therefore, clinical response was defined as a decrease in PUCAI by >15 points after FMT (17).”
BackgroundMethodTreating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003 · cited 2×
“Donor exclusion criteria were guided by our IND, the American Association of Blood Bank Donor History Questionnaire version 1.1, and the recommendations from the American Gastroenterological Association (16).”
BackgroundInfluentialHamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738 · cited 1×
“Multiple studies have used various bowel sterilizing preparations (antibiotics and bowel cleanout) before FMT (19,20) to help donor microbiota establish in the new host.”
BackgroundKhoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 2×
“Recent evidence suggests that FMT, the infusion of fecal preparation from a healthy donor into the GI tract of a patient, is capable of altering the gut microbiome of the new host (6,7).”
BackgroundMethodGophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F., & Veldhuyzen van Zanten, S. J. O. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01004-06 · Cited by 550
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503 · cited 1×
“The colonic microbiome in patients with UC has decreased richness and diversity (2,3) and is dysfunctional (4) (dysbiosis).”
BackgroundTursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489 · cited 1×
“Probiotics, for example, VSL#3, have shown some usefulness in the treatment of UC (5); however, not all probiotic formulations contain the same species, their efficacy may be strain specific, and understanding of their mechanism of action in the complex gastrointestinal (GI) microbiome is lacking.”
BackgroundTreatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388 · cited 3×
“As reported previously (10), because of the chronic process of colonic inflammation, multiple FMT sessions may be needed to see a clinical response in UC.”
BackgroundMethod
Cited by
Items 301–343 of 343
Simoes Brandao, M. I. (2016) · Gutenberg Open Science · doi:10.25358/openscience-4590 · Cited by 1
Fatores de risco microbiológicos e ambientais na doença inflamatória intestinal : uma revisão
Santos, N. F. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Intérêt des ligands alpha2-delta dans le traitement de la douleur viscérale inflammatoire.
Boudieu, L. (2014) · theses.fr (ABES) · doi:10.70675/004f8944z891az442fz9951z26aafe2c07aa · Cited by 1
Rôle des immunoglobulines sécrétoires dans les maladies inflammatoires chroniques de l'intestin
Michaud, E. (2020) · theses.fr (ABES) · doi:10.70675/92102dfez11caz4732zad57z20a2f16673e1 · Cited by 1
Medical Stool: The Future of Treatment for Inflammatory Bowel Disease?
Davidovics, Z. H., & Sylvester, F. A. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318295cc5a
“In this issue, Kunde et al report on 10 patients, 7 to 21 years of age, with mild to moderate ulcerative colitis (UC) who received retention fecal enemas for 5 consecutive days to treat their UC (6).”
BackgroundHost–microbe interactions in the gut: lessons learned from models of inflammatory bowel diseases
Wine, E. (2014) · LymphoSign Journal · doi:10.14785/lpsn-2014-0014
The microbiome and its therapeutic potential in inflammatory bowel diseases
Rossen, N. (2016) · UvA-DARE (University of Amsterdam)
II. Fecal Microbiota Transplantation and Its Clinical Application
Ohkusa, T., & Koido, S. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.42
Chan, C. (2016) · Scholarship - Claremont (Claremont Colleges)
Doit-on continuer à imposer une stomie d’amont systématique après une anastomose colorectale ?
Polo, R. M. (2017) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.071.0029
Transplantação fecal: o estado da arte
Almeida, M. J. G. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Ulcerative colitis associated with vitiligo and IgA deficiency in a young girl
Naumcieff, I., Burlea, M., Diaconescu, S., Chiriac, M. I., Olaru, C. A., Gimiga, N., Ciubotariu, G., Mihăilă, D., Ștefănescu, G., & Trandafir, L. M. (2017) · Archive of Clinical Cases · doi:10.22551/2017.14.0401.10092
The Different Drummer: Non-traditional Therapeutic Approaches
Yen, E. F. (2017) · Clinical gastroenterology · doi:10.1007/978-3-319-53763-4_12
Potencial terapêutico da saliva de Aedes aegypti na inflamação intestinal experimental
de Campos, H. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2017.tde-04052017-155140
Steinberg, R. (2016) · The Science Journal of the Lander College of Arts and Sciences
Studies of the aetiopathogenesis of pouchitis
Landy, J. (2014) · doi:10.25560/25735
Fecal Transplants in the Treatment of Recurrent Clostridium difficile Infection: A Case Study
Henderson, E. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/frhc-g977
Microbes in the Pathogenesis of Inflammatory Bowel Disease: A Review
Jatwani, S., Malhotra, B. K., Crout, T. M., & Majithia, V. (2019) · Springer eBooks · doi:10.1007/978-3-030-23311-2_37
Commentary: Update on disorders of the gastrointestinal tract in children
Nusbaum, D. J., & Michail, S. K. (2020) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2020.100800
Diarrhoea And Intestinal Microbiota
Tiburcio, Á. Z. (2020) · Journal of Clinical Case Reports and Studies · doi:10.31579/2690-8808/006
“The referenced authors have witnessed the importance of Intestinal Microbiota Transplantation in diseases as frequent as IBS, diarrhea variety [7], and the inflammatory processes of Ulcerative Colitis and Crohn's Disease, with generation of diarrheic evacuations [8-12], as well as the correction, with an enormous freq…”
BackgroundÇocuk Hastalara Uygulanan Fekal Mikrobiyota Transplantasyonuna Yönelik Hemşirelik Yaklaşımı
Tuğba, D. E. D. E., & İncekar, M. Ç. (2021) · Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi · doi:10.51261/yiu.2021.00039
Ramos, R. J. J. F., Zhu, C., Joseph, D. F., Thaker, S., LaComb, J. F., Markarian, K., Littmann, E. R., Lee, H. J., Petrov, J. C., Monzur, F., et al. (2022) · medRxiv · doi:10.1101/2022.02.11.22268733
“72 However, studies thus far on the effectiveness of FMT in the treatment of IBD, absent concomitant 73 CDI, have utilized different protocols and have yielded mixed results [16-27].”
ResultAttitudes and preferences toward fecal microbiota transplantation among patients with cancerPreprint
Zheng, R., Yue, Z., Fu, Y. M., Xiang, Q., Zhu, J., Chen, L., Yu, C., & Li, J. (2020) · Research Square · doi:10.21203/rs.3.rs-23402/v1
“Transient adverse responses were observed after FMT, including mild diarrhea, pain, fever, fatigue, and exhaustion [9, 25], but no additional studies have reported complications or adverse events [26–27].”
BackgroundDavidovics, Z. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00093-1
Transplante fecal y sus indicaciones
dos Reis, E. B. B., Batista, G. S., & Santos, P. C. F. (2023) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.16n.5-065
Ulcerative Colitis in Children and Adolescents
Michel, H. K., & Kim, S. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00043-4
Novel Biologics for the Treatment of Ulcerative Colitis
Rashid, F., & Lichtenstein, G. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1677-1_17
Clinical and microbiological studies of faecal microbiota transplantation in ulcerative colitis
Paramsothy, S. (2018) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/3506
Μεταμοσχεύσεις κοπράνων, μία μελέτη της μεθόδου και της σύγχρονης βιβλιογραφίας
Καραμπέκος, Γ. (2017) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.7011
Mecanismos fisiopatológicos e novos alvos farmacológicos na doença inflamatória intestinal
Cruz, M. J. V. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Illuminating the metabolism of the microbiota using dietary sugar-fluorophore constructs
Montagut, A. (2018) · eScholarship@McGill (McGill) · doi:10.82308/27006
The role of the gut microbiota in etiology and management of ulcerative colitis. Α literature review
Καφετζής, Γ. Κ., & Καφετζής, Γ. Κ. (2024) · University of Thessaly Institutional Repository (University of Thessaly)
Therapeutic activity of Aedes aegypti saliva in experimental colitis
de Campos, H. S. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Langhorst, J., & Langhorst, A. (2026) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-026-02346-6
Moser, K., Ballif, A., Becker, D., Carrez, L., Audry, M., Gerber, S., & Galpérine, T. (2026) · Swiss Medical Weekly · doi:10.57187/5144
刘铮, Mo, W., 梁靜蓉, Li, L., Liu, S., Xu, H., Ruan, H., Liang, C., Qin, J., Yao, L., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1948431
Metadata
- Authors
- Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H., Cloney, D., & Kugathasan, S.
- Affiliations
- Spectrum Health (US)
- Michigan State University (US)
- Emory University (US)
- Corresponding author
- Kunde, Sachin
- Pham, Angela
- Crumb, Teri
- Duba, Meg
- Conrad, Harold
- Cloney, Deborah
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2013-06
- Volume
- 56
- Issue
- 6
- Pages
- 597-601
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2121245825
- Cited by
- 314
- References
- 26
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 8 · 2023: 14 · 2022: 14 · 2021: 17 · 2020: 26 · 2019: 26 · 2018: 23 · 2017: 40 · 2016: 34 · 2015: 38 · 2014: 42 · 2013: 16
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Surgery › Anorectal Disease Treatments and Outcomes
- Keywords
- fecal microbiota transplantation, ulcerative colitis, pediatric inflammatory bowel disease, colonic dysbiosis, clinical remission, safety and tolerability, adverse events, disease activity
- MeSH terms
- Administration, Rectal, Adolescent, Adult, Biological Therapy, Child, Colitis, Ulcerative, Family, Feasibility Studies, Feces, Female, Follow-Up Studies, Hospitals, Pediatric, Humans, Male, Michigan, Outpatient Clinics, Hospital, Pilot Projects, Remission Induction, Severity of Illness Index, Therapies, Investigational, Donor Selection, Young Adult, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.